iDose TR
These highlights do not include all the information needed to use iDose TR safely and effectively. See full prescribing information for iDose TR. iDose TR (travoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001
Approved
Approval ID
92f6d3e2-8328-47df-972c-23008f4a1c1c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 20, 2023
Manufacturers
FDA
Glaukos Corporation
DUNS: 012835406
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Travoprost Intracameral
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code25357-100
Application NumberNDA218010
Product Classification
M
Marketing Category
C73594
G
Generic Name
Travoprost Intracameral
Product Specifications
Route of AdministrationINTRACAMERAL
Effective DateDecember 20, 2023
FDA Product Classification
INGREDIENTS (1)
TRAVOPROSTActive
Quantity: 75 ug in 1 1
Code: WJ68R08KX9
Classification: ACTIB